Paion AG (LTS:0NF3) Other Current Liabilities: €3.16 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0NF3 Paion AG LTS:0NF3
10 GF Score
Price €0.01
View Full Analysis

What is Paion AG Other Current Liabilities?

Paion AG LTS:0NF3 10 Other Current Liabilities is €3.16 Mil as of Jun. 2023. GuruFocus rates LTS:0NF3 with a GF Score™ of 10/100.

Paion AG's other current liabilities for the quarter that ended in Jun. 2023 was €3.16 Mil.

Paion AG's quarterly other current liabilities declined from Jun. 2022 (€3.50 Mil) to Dec. 2022 (€2.86 Mil) but then increased from Dec. 2022 (€2.86 Mil) to Jun. 2023 (€3.16 Mil).

Paion AG's annual other current liabilities declined from Dec. 2020 (€2.80 Mil) to Dec. 2021 (€2.71 Mil) but then increased from Dec. 2021 (€2.71 Mil) to Dec. 2022 (€2.86 Mil).

Paion AG Other Current Liabilities Related Terms

Paion AG Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Paion AG's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paion AG Other Current Liabilities Chart

Paion AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 0.69 2.80 2.71 2.86

Paion AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 2.71 3.50 2.86 3.16
LTS:0NF3
10GF Score
Paion AG LTS:0NF3
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paion AG Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €3.16 Mil mean?
Paion AG (LTS:0NF3) has a Other Current Liabilities of €3.16 Mil as of Jun. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Paion AG.
Is Paion AG's Other Current Liabilities too high?
Paion AG's current Other Current Liabilities is €3.16 Mil. Overall, Paion AG has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Paion AG's Other Current Liabilities compare to ZTS and NBIX?
Paion AG's Other Current Liabilities of €3.16 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Paion AG. Paion AG's current Other Current Liabilities is €3.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paion AG stock overvalued right now?
Paion AG (LTS:0NF3) has a current Other Current Liabilities of €3.16 Mil. The current Other Current Liabilities is €3.16 Mil. Paion AG's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Paion AG (LTS:0NF3), the current Other Current Liabilities is €3.16 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Paion AG Business Description

Address Heussstrasse 25, Aachen, DEU, 52078
Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
10GF Score

Get the complete analysis for LTS:0NF3

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price